TransMedics (TMDX) Profit After Tax Growth (3y) (2021 - 2026)
TransMedics (TMDX) Profit After Tax Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.85% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 6.53% |
| 10 | TransMedics | 2.72 Bn | 2.26 Bn | 101.16 Mn | 68.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.39% |
| Dec 31, 2025 | 160.52% |
| Sep 30, 2025 | 74.08% |
| Jun 30, 2025 | 71.33% |
| Mar 31, 2025 | 64.25% |
| Dec 31, 2024 | 36.51% |
| Sep 30, 2024 | 32.48% |
| Jun 30, 2024 | 46.48% |
| Mar 31, 2024 | 52.41% |
| Dec 31, 2023 | 38.19% |
| Sep 30, 2023 | -70.96% |
| Jun 30, 2023 | 50.98% |
| Mar 31, 2023 | 33.22% |
| Dec 31, 2022 | 9.87% |
| Sep 30, 2022 | 3.56% |
| Jun 30, 2022 | -7.81% |
| Mar 31, 2022 | -15.28% |
| Dec 31, 2021 | -18.39% |
| Sep 30, 2021 | -36.42% |
| Jun 30, 2021 | -20.38% |